Eris Lifesciences Share Price

Eris Lifesciences Share Price

  • 1,365.70-1.21 (-0.09%)
  • Live
  • As On: 11 Jun, 2026, 09:28 AM IST
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Try ETMarkets GPTNEW
Open1,365.00
High1,376.50
Low1,337.60
Prev Close1,366.90
Volume12,462
VWAP(₹)1,354.69

Key Metrics

PE Ratio(x)30.57
EPS - TTM(₹)44.72
MCap(₹ Cr.)18,937.43
MCap Rank30
PB Ratio(x)4.86
Div Yield(%)0.53
Face Value(₹)1.00
52W High(₹)1,910.00
52W Low(₹)1,200.00
MCap/Sales5.75
Beta(1 Month)0.09
BV/Share(₹)281.19

Eris Lifesciences share price insights

  • Intraday fact check

    In the last 9 years, only 0.86 % trading sessions saw intraday declines higher than 5 % .

  • Quarterly Topline Performance

    Company witnessed QoQ revenue decline of 6.03%, which is lowest in the last 3 years. (Source: Consolidated Financials)

  • Employee & Interest Expense

    Company has spent 6.16% of its operating revenues towards interest expenses and 17.79% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

  • Eris Lifesciences Share Price Update

    Eris Lifesciences Ltd. share price moved down by -0.09% from its previous close of Rs 1,366.90. Eris Lifesciences Ltd. stock last traded price is 1,365.70

    Share PriceValue
    Today/Current/Last1,365.70
    Previous Day1,366.90

Found Insights useful?

Eris Lifesciences Share Price Returns

1 Day-0.09%
1 Month-0.78%
3 Months1.22%
1 Year-20.38%
3 Years111.59%
5 Years93.59%

Eris Lifesciences Share Recommendations

Mean recosCurrent
BUY

10 Analysts

Strong
SellSellHoldBuyStrong
Buy
Analyst Trends
RatingsCurrent1W Ago1M Ago3M Ago
Strong Buy5544
Buy4455
Hold1111
Sell----
Strong Sell----
# Analysts10101010
Recent Recos
  • Target₹1100
  • OrganizationPrabhudas Lilladher
  • BUY
  • Target₹930
  • OrganizationMotilal Oswal Financial Services
  • NEUTRAL
  • Target₹1070
  • OrganizationHDFC Securities
  • BUY
View all Stock Recommendations

News & Analysis

View all Eris Lifesciences Share News & Announcements

Financials

  • Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
    Total Income807.47795.22775.69713.25731.67
    Total Income Growth (%)1.542.528.75-2.52-1.88
    Total Expenses613.42573.28566.80530.16558.34
    Total Expenses Growth (%)7.001.146.91-5.050.22
    EBIT194.05221.94208.89183.09173.33
    EBIT Growth (%)-12.576.2514.095.63-8.09
    Profit after Tax (PAT)99.72120.19117.9993.8483.63
    PAT Growth (%)-17.031.8625.7412.21-8.69
    EBIT Margin (%)24.0327.9126.9325.6723.69
    Net Profit Margin (%)12.3515.1115.2113.1611.43
    Basic EPS (₹)7.328.828.666.906.15
    Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
    Total Income340.36674.09601.32421.52407.52
    Total Income Growth (%)-49.5112.1042.663.44-7.88
    Total Expenses291.27392.92399.92327.18346.84
    Total Expenses Growth (%)-25.87-1.7522.23-5.671.98
    EBIT49.09281.17201.4094.3460.68
    EBIT Growth (%)-82.5439.61113.4855.47-40.67
    Profit after Tax (PAT)3.09149.5799.9930.471.78
    PAT Growth (%)-97.9349.58228.161,611.80-93.67
    EBIT Margin (%)14.4241.7133.4922.3814.89
    Net Profit Margin (%)0.9122.1916.637.230.44
    Basic EPS (₹)0.2310.987.342.240.13
    FY 2025FY 2024FY 2023FY 2022FY 2021
    Total Revenue2,912.002,032.961,696.301,373.141,220.57
    Total Revenue Growth (%)43.2419.8523.5312.5012.04
    Total Expenses2,423.191,601.721,291.66930.94826.07
    Total Expenses Growth (%)51.2924.0038.7512.698.97
    Profit after Tax (PAT)351.84391.98382.16406.11355.14
    PAT Growth (%)-10.242.57-5.9014.3519.78
    Operating Profit Margin (%)24.8825.6825.5633.1332.70
    Net Profit Margin (%)12.1519.5022.6730.1429.30
    Basic EPS (₹)25.8528.8228.1029.8926.16
    FY 2025FY 2024FY 2023FY 2022FY 2021
    Total Revenue1,733.261,521.531,347.991,244.721,118.83
    Total Revenue Growth (%)13.9212.878.3011.258.10
    Total Expenses1,613.211,192.70911.08786.18729.94
    Total Expenses Growth (%)35.2630.9115.897.712.61
    Profit after Tax (PAT)77.39299.71398.01417.19350.61
    PAT Growth (%)-74.18-24.70-4.6018.9920.37
    Operating Profit Margin (%)20.0425.9834.3937.9635.14
    Net Profit Margin (%)4.5520.1529.9034.3131.61
    Basic EPS (₹)5.6922.0429.2730.7025.82

    All figures in Rs Cr, unless mentioned otherwise

    Insights

    • Quarterly Topline Performance

      Company witnessed QoQ revenue decline of 6.03%, which is lowest in the last 3 years. (Source: Consolidated Financials)

    • Employee & Interest Expense

      Company has spent 6.16% of its operating revenues towards interest expenses and 17.79% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
    View Details
  • AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Total Assets7,033.177,048.843,667.332,272.141,834.78
    Total Assets Growth (%)-0.2292.2161.4023.8418.20
    Total Liabilities3,761.413,826.811,446.65363.94258.36
    Total Liabilities Growth (%)-1.71164.53297.5040.870.93
    Total Equity3,271.763,222.032,220.681,908.201,576.42
    Total Equity Growth (%)1.5445.0916.3821.0521.61
    Current Ratio (x)0.890.911.733.142.80
    Total Debt to Equity (x)0.851.060.380.020.00
    Contingent Liabilities68.011,510.0231.2327.4019.60
    AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Total Assets5,222.435,349.572,783.662,150.421,754.80
    Total Assets Growth (%)-2.3892.1829.4522.5518.32
    Total Liabilities2,707.532,825.55561.77231.86179.34
    Total Liabilities Growth (%)-4.18402.97142.2929.29-2.23
    Total Equity2,514.902,524.022,221.881,918.561,575.47
    Total Equity Growth (%)-0.3613.6015.8121.7821.22
    Current Ratio (x)0.630.831.953.492.93
    Total Debt to Equity (x)0.881.000.140.000.00
    Contingent Liabilities684.541,507.0226.2327.2321.21

    All figures in Rs Cr, unless mentioned otherwise

    View Details
  • AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Net Cash flow from Operating Activities1,065.01486.01291.74378.26375.36
    Net Cash used in Investing Activities-79.97-1,854.52-982.10-319.61-323.36
    Net Cash flow from Financing Activities-881.321,379.78688.03-44.70-82.40
    Net Cash Flow105.4911.265.1513.96-30.39
    Closing Cash & Cash Equivalent199.7494.2556.0250.8736.92
    Closing Cash & Cash Equivalent Growth (%)111.9468.2310.1337.80-45.15
    Total Debt/ CFO (x)2.275.632.850.120.00
    AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Net Cash flow from Operating Activities701.86336.29322.33369.41395.41
    Net Cash used in Investing Activities-358.99-2,491.89-513.30-267.64-347.86
    Net Cash flow from Financing Activities-310.462,160.06193.75-88.42-81.13
    Net Cash Flow32.414.452.7813.36-33.58
    Closing Cash & Cash Equivalent84.3451.9447.4844.7031.35
    Closing Cash & Cash Equivalent Growth (%)62.409.386.2142.61-51.72
    Total Debt/ CFO (x)3.157.520.980.000.00

    All figures in Rs Cr, unless mentioned otherwise

    Insights

    • Increase in Cash from Investing

      Company has used Rs 369.46 cr for investing activities which is an YoY increase of 362.0%. (Source: Consolidated Financials)
    View Details
  • AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Return on Equity (%)12.3215.1517.4021.2822.52
    Return on Capital Employed (%)12.7411.4213.3621.5323.76
    Return on Assets (%)5.005.5610.4217.8719.35
    Interest Coverage Ratio (x)4.488.2420.94123.26219.92
    Asset Turnover Ratio (x)0.410.370.530.6166.04
    Price to Earnings (x)54.9529.2420.3723.0923.15
    Price to Book (x)6.764.423.544.915.21
    EV/EBITDA (x)21.1619.2015.6518.3118.60
    EBITDA Margin (%)35.7834.7732.5137.9336.24
    AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Return on Equity (%)3.0711.8717.9121.7522.25
    Return on Capital Employed (%)8.0412.5018.3023.2624.19
    Return on Assets (%)1.485.6014.2919.4019.97
    Interest Coverage Ratio (x)2.378.5125.10171.51500.86
    Asset Turnover Ratio (x)0.320.370.540.6263.18
    Price to Earnings (x)250.0038.3119.5722.4723.42
    Price to Book (x)7.674.533.504.885.21
    EV/EBITDA (x)41.0225.9415.4118.1719.13
    EBITDA Margin (%)30.7532.8639.2542.1938.53

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP

Technicals

  • Stochastic Crossover

    Bearish signal on weekly chart

    Appeared on: 5 Jun 2026

    Region: Equlibrium

    Last Signal 8 May 2026 (Loss -4.62%)

    Average price decline of -6.85% within 7 weeks of Bearish signal in last 10 years

  • 45%
    Positive Movement
    since 1st Jan 2005
    on basis
    55%
    Negative Movement
    since 1st Jan 2005
    on basis
    Exclude

    Global Meltdown1st Jan 2008 to 10th Nov 2008

    Covid Crisis1st Feb 2020 to 31st Mar 2020

  • R11379.53Pivot

    1371.37

    		S11358.73
    R21392.17S21350.57
    R31412.97S31329.77
  • 5 Days14 Days28 Days
    34.3745.8548.65

Found Technicals useful?

Peer Comparison

Shareholding Pattern

  • CategoryNo. of SharesPercentage% Change QoQ
    Promoters7,47,08,74453.92 %-0.92
    Pledge1,26,41,47016.92 %0.00
    FII88,59,1186.39 %-0.45
    DII2,81,93,94320.34 %0.03
    MF2,52,42,37418.22 %-0.04
    Others2,67,81,08219.34 %1.35
  • CategoryMar 2026Dec 2025Sep 2025Jun 2025
    Promoters53.9254.8554.8554.83
    Pledge16.9216.9216.9216.93
    FII6.396.857.218.39
    DII20.3420.3119.3618.18
    Mutual Funds18.2218.2617.3316.78
    Others19.3417.9818.5818.59

Mutual Funds Ownership

MF Ownership as on 30 April 2026

View all Mutual Fund Schemes

Eris Lifesciences Top Searches

    Corporate Actions

    • Interim Dividend

      721%

      May 20, 2026

      Board Meeting

      Audited Results & Interim Dividend

      May 15, 2026

      General Meeting

      -

      Apr 23, 2026

    • Announced onMeeting on
      May 15, 2026May 20, 2026
      Audited Results & Interim Dividend
      Feb 06, 2026Feb 13, 2026
      Quarterly Results
      Nov 20, 2025Nov 24, 2025
      Preferential issue of shares
      Nov 06, 2025Nov 12, 2025
      Quarterly Results
      Jul 30, 2025Aug 05, 2025
      Quarterly Results
    • Announced onEx-DateDividend%
      May 20, 2026May 29, 2026721%
      Feb 06, 2025Feb 13, 2025735%
      Aug 02, 2022Aug 11, 2022735%
      Jul 26, 2021Aug 05, 2021601%
      Aug 04, 2020Aug 13, 2020550%

    • No Data Available

    • No Data Available

    • No Data Available

    • Announced onMeeting on
      Apr 23, 2026May 25, 2026
      -
      Nov 25, 2025Dec 26, 2025
      -
      Jul 03, 2025Jul 25, 2025
      -
      Sep 04, 2024Sep 25, 2024
      A.G.M.
      Sep 08, 2023Sep 25, 2023
      A.G.M.

    About Eris Lifesciences

    Eris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 18,937.43 Crore) operating in Pharmaceuticals sector.

    Show More

    Industry

    Pharma - Indian

    Key Indices Listed On

    Nifty 500, BSE 500, BSE 250 SmallCap Index, BSE SmallCap, BSE Healthcare

    Address

    Shivarth Ambit, Plot No. 142/2,Ramdas Road, Off SBR,Near Swati Bungalows,Ahmedabad, Gujarat - 380054

    Contact

    complianceofficer@erislifesciences.com

    http://www.eris.co.in

    Executive Leadership

    AB

    Amit Bakshi

    Chairperson & Managing Director
    KV

    Krishnakumar Vaidyanathan

    COO & Executive Director
    IS

    Inderjeet Singh Negi

    Executive Director
    KS

    Kaushal Shah

    Executive Director
    Show More

    Auditors

    Deloitte Haskins & Sells LLP

    FAQs about Eris Lifesciences share

    • 1. What's Eris Lifesciences share price today and what are Eris Lifesciences share returns ?
      Eris Lifesciences share price is Rs 1,365.70 as on 11 Jun, 2026, 09:28 AM IST. Eris Lifesciences share price is down by 0.09% based on previous share price of Rs 1,373.7. Eris Lifesciences share price trend:
      • Last 12 Months: Eris Lifesciences share price moved down 20.38%
      • Last 3 Years: Eris Lifesciences Share price moved up by 111.59%
    • 2. What is the PE & PB ratio of Eris Lifesciences?
      The PE ratio of Eris Lifesciences stands at 30.57, while the PB ratio is 4.86.
    • 3. What has been highest price of Eris Lifesciences share in last 52 weeks?
      In last 52 weeks Eris Lifesciences share had a high price of Rs 1,910.00 and low price of Rs 1,200.00
    • 4. What are the returns for Eris Lifesciences share?
      Return Performance of Eris Lifesciences Shares:
      • 1 Week: Eris Lifesciences share price moved down by 0.12%
    • 5. What is the market cap of Eris Lifesciences?
      Market Capitalization of Eris Lifesciences stock is Rs 18,937.43 Cr.

    Top Gainers

    As on 09:29 AM | 11 Jun 2026
    Blue Jet Healthcare
    499.50
    29.75 (6.34%)
    SCI
    299.45
    11.95 (4.16%)
    Aegis Logistics
    830.95
    29.96 (3.74%)
    Zee Ent.
    106.16
    3.23 (3.14%)
    Tata Chemicals
    740.85
    20.46 (2.84%)

    Top Losers

    As on 09:29 AM | 11 Jun 2026
    HFCL
    160.66
    -8.46 (-5.00%)
    Oracle
    9,140.00
    -330.00 (-3.49%)
    Afcons Infrastru
    319.35
    -10.70 (-3.25%)
    Persistent System
    4,769.00
    -159.00 (-3.23%)
    Inox India
    1,831.40
    -60.20 (-3.19%)

    Equity Quick Links

    Top Gainers
    Top Losers
    Hourly gainers
    Hourly losers
    Sensex
    Nifty
    NSE
    BSE
    Midcap stocks
    Smallcap stocks
    Largecap stocks
    Sensex
    Nifty
    NSE
    BSE
    MCX Live

    More from Markets

    IPO
    Stock market news
    Budget 2022 Live Updates
    Cryptocurrency
    Currency converter
    NSE holiday list

    Trending in Markets

    DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

    DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

    By using this site, you agree to the Terms of Service and Privacy Policy.

    Business News › Markets › Stocks › Stock Price Quotes › Eris Lifesciences Share Price

    Browse Companies

    ABCDEFGHIJKLMNOPQRSTUVWXYZ
    123456789

    Popular Categories

    Hot on Web

    In Case you missed it

    Top Searched Companies

    Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
    Times Syndication Service

    Do Not Sell My Personal Information